Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
40
PRKR Quote, Financials, Valuation and Earnings
Last price:
$0.46
Seasonality move
:
14.26%
Day range:
$0.42 - $0.48
52-week range:
$0.09 - $1.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
116.3K
Avg. volume:
105.6K
1-year change:
199%
Market cap:
$56.2M
Revenue:
$25M
EPS (TTM):
-$0.16
Earnings Data
Next earnings date for PRKR
Aug 13
2025
Most recent earnings per share
-$0.03
Missed by $0.03
(Mar 24/2025)
Consensus Estimate
--
(Mar 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PRKR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2025 | Q4 | -- | -- | -$0.03 | -- | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.12 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$0.00 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$0.01 | -- | -- |
| 03/22/2024 | Q4 | -- | -- | -$0.01 | -- | -- |
| 11/14/2023 | Q3 | -- | -- | -$0.05 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | $0.16 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.07 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.01 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.06 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.03 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.06 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.04 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.03 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.08 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.21 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.11 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.07 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.05 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.07 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.26 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.19 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.18 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.19 | -$0.21 | $0.02 |
| 03/30/2018 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/14/2017 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/14/2017 | Q2 | -- | -- | -$0.21 | -- | -- |
| 05/15/2017 | Q1 | -- | -- | -$0.32 | -- | -- |
| 03/30/2017 | Q4 | -- | -- | -$0.43 | -- | -- |
| 11/14/2016 | Q3 | -- | -- | -$0.18 | -- | -- |
| 08/15/2016 | Q2 | -- | -- | -$0.72 | -- | -- |
| 05/16/2016 | Q1 | -- | -- | -$0.45 | -- | -- |
| 03/30/2016 | Q4 | -- | -- | -$0.34 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.32 | -- | -- |
| 08/10/2015 | Q2 | -- | -- | -$0.50 | -- | -- |
Parkervision Earnings Questions
-
How Much did Parkervision Generate in Revenue Last Quarter?
Parkervision reported -- worth of top line sales in its most recent quarter.
-
Did Parkervision Beat Earnings Last Quarter?
Parkervision announced earnings per share of -$0.03 which represents a miss of analyst forecast a -- per share.
-
Is Parkervision Profitable?
Parkervision reported -$55K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Parkervision EPS Next Year?
Parkervision's earnings are forecast to grow from -$0.16 per share to -- per share next year representing an increase of --.
-
When is Parkervision's Earnings Date?
Parkervision's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 19
Semler Scientific [SMLR] is up 5.85% over the past day.
Sell
25
GLOB alert for May 19
Globant SA [GLOB] is up 4.02% over the past day.
Buy
94
HIMS alert for May 19
Hims & Hers Health [HIMS] is down 3.57% over the past day.
